Company record
Sourav K. Mishra, M.D. / All India Institute of Medical Sciences
1 FDA warning letter since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Sourav K. Mishra, M.D. / All India Institute of Medical Sciences.
Warning letters
-
DrugsSourav K. Mishra, M.D. / All India Institute of Medical Sciences
FDA warned clinical investigator Dr. Sourav K. Mishra at AIIMS Bhubaneswar over a doxorubicin liposome bioequivalence study that broke protocol and consent rules.
High risk